Binetti, G. et al. (1995). Delusions and dementia: clinical and CT correlates. Acta Neurologica Scandinavica, 91, 271–275.
Blackwood, N. J., Howard, R. J., Bentall, R. P. and Murray, R. M. (2001). Cognitive neuropsychiatric models of persecutory delusions. American Journal of Psychiatry, 158, 527–539.
Bruen, P. D., McGeown, W. J., Shanks, M. F. and Venneri, A. (2008). Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain, 131, 2455–2463.
Burns, A. (1996). The Institute of Psychiatry Alzheimer's disease cohort 1986–1992. 1. Clinical observations. International Journal of Geriatric Psychiatry, 11, 309–320.
Cummings, J. L. (1997). The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology, 48, S10–S16.
Drury, V. M., Robinson, E. J. and Birchwood, M. (1998). “Theory of mind” skills during an acute episode of psychosis and following recovery. Psychological Medicine, 28, 1101–1112.
Fischer, C., Bozanovic, R., Atkins, J. H. and Rourke, S. B. (2006). Treatment of delusions in Alzheimer's disease: response to pharmacotherapy. Dementia and Geriatric Cognitive Disorders, 22, 260–266.
Fischl, B. and Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America, 97, 11050–11055.
Fischl, B. et al. (2004). Sequence-independent segmentation of magnetic resonance images. Neuroimage, 23, S69–S84.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: practical method for grading cognitive state of patients for clinician. Journal of Psychiatric Research, 12, 189–198.
Fukuhara, R. et al. (2001). Alteration of rCBF in Alzheimer's disease patients with delusions of theft. Neuroreport, 12, 2473–2476.
Geroldi, C., Bresciani, L., Zanetti, O. and Frisoni, G. B. (2002). Regional brain atrophy in patients with mild Alzheimer's disease and delusions. International Psychogeriatrics, 14, 365–378.
Kloszewska, I. (1998). Incidence and relationship between behavioural and psychological symptoms in Alzheimer's disease. International Journal of Geriatric Psychiatry, 13, 785–792.
Lee, D. Y. et al. (2006). White matter changes associated with psychotic symptoms in Alzheimer's disease patients. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 191–198.
Lovestone, S., Francis, P. and Strandgaard, K. (2007). Biomarkers for disease modification trials: the innovative medicines initiative and AddNeuroMed. Journal of Nutrition Health and Aging, 11, 359–361.
Magni, E., Binetti, G., Bianchetti, A. and Trabucchi, M. (1996). Risk of mortality and institutionalization in demented patients with delusions. Journal of Geriatric Psychiatry and Neurology, 9, 123–126.
Mega, M. S., Lee, L., Dinov, I. D., Mishkin, F., Toga, A. W. and Cummings, J. L. (2000). Cerebral correlates of psychotic symptoms in Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 69, 167–171.
Mentis, M. J. et al. (1995). Abnormal brain glucose-metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biological Psychiatry, 38, 438–449.
Moran, E. K., Becker, J. A., Satlin, A., Lyoo, I. K., Fischman, A. J. and Johnson, K. A. (2008). Psychosis of Alzheimer's disease: gender differences in regional perfusion. Neurobiology of Aging, 29, 1218–1225.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
Nakano, S., Yamashita, F., Matsuda, H., Kodama, C. and Yamada, T. (2006). Relationship between delusions and regional cerebral blood flow in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 21, 16–21.
Phillips, M. L., Senior, C. and David, A. S. (2000). Perception of threat in schizophrenics with persecutory delusions: an investigation using visual scan paths. Psychological Medicine, 30, 157–167.
Reeves, S., Brown, R., Howard, R. and Grasby, P. (2009). Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease. Neurology, 72, 528–534.
Reisberg, B., Ferris, S. H., Deleon, M. J. and Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136–1139.
Rosen, W. G., Mohs, R. C. and Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356–1364.
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943.
Simmons, A. et al. for the AddNeuroMed Consortium (2011). The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. International Journal of Geriatric Psychiatry, 26, 75–82.
Sultzer, D. L., Brown, C. V., Mandelkern, M. A., Mahler, M. E., Chen, S. T. and Cummings, J. L. (2003). Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. American Journal of Psychiatry, 160, 341–349.
Whittaker, J. F., Deakin, J. F. W. and Tomenson, B. (2001). Face processing in schizophrenia: defining the deficit. Psychological Medicine, 31, 499–507.
Young, H. F. and Bentall, R. P. (1997). Probabilistic reasoning in deluded, depressed and normal subjects: effects of task difficulty and meaningful versus non-meaningful material. Psychological Medicine, 27, 455–465.